Dr. Kate Hillier advises clients in the healthcare and life sciences industry on complex transactions and licensing issues. She represents public and private companies on a range of matters related to discovering, developing, and marketing, biopharmaceuticals, vaccines, digital health and AI-enabled platforms and products, medical devices and diagnostics. Kate has practiced in both the US and the UK in the life sciences and health care transactions field. Kate draws on her academic and clinical experience to maximize the value of clients’ products and technologies, regularly advising companies on strategic intellectual property licensing, collaboration agreements, and structuring and negotiating critical transactions. She also counsels clients on matters involving foundational in-licenses and complex commercial arrangements. Before her legal career, Kate worked as a qualified anesthesiologist in Australia and the UK, completing her residency in anesthesiology and intensive care, before transitioning to law.